---
figid: PMC10378008__cimb-45-00386-g006
pmcid: PMC10378008
image_filename: PMC10378008__cimb-45-00386-g006.jpg
figure_link: /pmc/articles/PMC10378008/figure/F6/
number: Figure 6
figure_title: Correlations of PODNL1 expressions with the core molecules and biology
  pathways related to tumor immunotherapeutic responses.
caption: 'Correlations of PODNL1 expressions with the core molecules and biology pathways
  related to tumor immunotherapeutic responses. Correlation heatmaps: (A) Pathways
  (including Pan_F_TBRs, EMT markers, angiogenesis, ferroptosis, tumor inflammation
  signature, tumor proliferation signature, homologous recombination, G2M checkpoint,
  DNA replication, DNA repair and antigen-processing machinery). (B) Immune checkpoint.
  (C) Immunostimulator. (D) Chemokine. (E) Chemokine receptor. (F) MHC. (G) Tumor
  stem cell marker. (H) TMB. (I) MSI. * p < 0.05, ** p < 0.01, *** p < 0.001'
article_title: Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor
  Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting
citation: Geyang Dai, et al. Curr Issues Mol Biol. 2023 Jul;45(7).
year: '2023'
pub_date: 2023-7-
epub_date: 2023-7-22
doi: 10.3390/cimb45070386
journal_title: Current Issues in Molecular Biology
journa_nlm_ta: Curr Issues Mol Biol
publisher_name: MDPI
keywords:
- podocan-like protein 1 (PODNL1)
- pan-cancer
- small leucine-rich proteoglycans (SLRPs)
- extracellular matrix (ECM)
- matrix-mediated biomarker
- immunotherapy
---
